Testing safety of multiple EO2002 eye drops for corneal swelling
Treatments studied
Part of Eyes & vision, Genetic & congenital clinical trials.
This Phase 1 study tests whether EO2002 eye drops are safe and well tolerated in people with painful corneal swelling caused by the cornea’s inner lining not working well. It focuses on safety first, but your eye symptoms and vision may be monitored to see how you respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a natural lens or a lens implant, with the lens in the “bag” or a specific place called the sulcus
- Have corneal swelling (corneal edema) from inner-corneal dysfunction, such as Fuchs’ corneal dystrophy or bullous keratopathy
- Not have other cornea problems besides the study condition
- Not have had certain recent or complex eye surgeries (like laser/scarring procedures on the eye, vitrectomy, or cornea transplant types) in the past few months
- Your eye pressure must be within a safe range (not too high and not too low)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational cell therapy called EO2002 for people with corneal edema (swelling of the clear front part of the eye) caused by endothelial dysfunction, which can happen with Fuchs dystrophy or after cataract surgery. The treatment aims to restore the inner layer of the cornea to reduce swelling and improve vision.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
This Phase 1 trial tests a new, lab-made tissue transplant to improve corneal clarity in people with certain types of corneal endothelium failure (eye swelling) caused by specific conditions. The main goal is to check safety and see if vision and corneal health improve.
Hear when a new Corneal Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.